allopurinol and Hodgkin-Disease

allopurinol has been researched along with Hodgkin-Disease* in 6 studies

Reviews

1 review(s) available for allopurinol and Hodgkin-Disease

ArticleYear
The biochemistry of ferritin and its clinical implications.
    Progress in hematology, 1975, Volume: 9

    Topics: Amino Acid Sequence; Apoferritins; Electrophoresis; Female; Ferritins; Hemochromatosis; Hodgkin Disease; Humans; Iron; Leukemia; Liver; Liver Diseases; Male; Molecular Conformation; Molecular Weight; Oxidoreductases; Xanthine Oxidase

1975

Other Studies

5 other study(ies) available for allopurinol and Hodgkin-Disease

ArticleYear
[Acquired ichthyosis and haematological malignancies: five cases].
    Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:1

    Acquired ichthyosis is a rare condition that can reveal an unsuspected haematological malignancy, thus allowing early diagnosis and management. If ichthyosis regresses under treatment for the haematological disorder, its recurrence reflects a turning point in the course of the disease and implies worsening of the prognosis.. The patients were examined at a joint dermatology/haematology consultation. The diagnosis of ichthyosis was based on clinical examination alone with no patients undergoing skin biopsy.. Our series included three men and two women aged 38 to 65 years consulting for a variety of reasons including asthenia, anaemia and adenopathy. Ichthyosis occurred 2 to 9 months after the initial symptoms of the blood disease. Lesions consisted of diffuse brown scales. The disease was associated with lymphadenopathy and biological inflammatory syndrome. Two patients were presenting non-Hodgkin lymphoma, one had Hodgkin's disease, one had chronic myeloid leukaemia in progression and one had an undifferentiated lymphomatous process. Treatment was based on chemotherapy and emollients. The ichthyosis progressed in step with the underlying malignancy in all cases, with regression being complete in three cases, partial in one case and absent in one case.. In rare cases, acquired ichthyosis reveals systemic disease, and may be of infectious, endocrine or drug origin; it may also be idiopathic. However, it is most often a paraneoplastic syndrome with cutaneous expression encountered during haematological malignancies. Because of the variety of causative blood dyscrasias, ichthyosis cannot be used to guide their diagnosis, although it remains a reliable monitoring tool.. Acquired ichthyosis should prompt the clinician to search for a neoplastic condition, primarily a haematological disorder, guided by other associated signs, given that in our study, skin lesions generally appear to precede signs of the blood disease.

    Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematologic Neoplasms; Hodgkin Disease; Humans; Ichthyosis; Imatinib Mesylate; Leukemia, Myeloid, Accelerated Phase; Lung Neoplasms; Lymphoma, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Parotid Neoplasms; Piperazines; Platelet Aggregation Inhibitors; Prednisone; Procarbazine; Pyrimidines; Retrospective Studies; Rituximab; Schizophrenia; Stomach Neoplasms; Vincristine

2012
Path model of multidimensional compliance with cancer therapy.
    Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 1987, Volume: 6, Issue:3

    Patients newly diagnosed with hematologic malignancies were followed for a 6-month treatment period to assess compliance with three regimen requirements for cancer therapy: anti-neoplastic medication self-administered intermittently, supportive medication self-administered daily, and monthly clinic appointments. The effect on compliance of three intervention "packages" (some combination of education, shaping of pill-taking behavior, and home restructuring) and the extent that patient satisfaction, knowledge, and uncertainty about illness-related events mediated the effects of the interventions were also examined. Blood levels of the drugs and self-report measures indicated that compliance with daily pill taking was higher for each intervention group compared to a control group. Similar results were obtained for compliance with clinic appointments. No improvement in intermittent self-medication was found. Although each intervention package increased patient knowledge and satisfaction, path analyses demonstrated that knowledge did not affect any aspect of compliance, whereas satisfaction was associated with increased appointment keeping only. Daily pill taking was influenced directly by the behavioral components of the interventions. Uncertainty did not influence compliance but was associated with depression, which was negatively correlated with intermittent self-medication.

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Hodgkin Disease; Humans; Leukemia; Lymphoma; Middle Aged; Multiple Myeloma; Patient Compliance; Patient Education as Topic; Prednisone

1987
The effect of Milurit on secondary hyperuricaemia following cytostatic treatment in haemoblastosis patients.
    Therapia Hungarica (English edition), 1979, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Aged; Allopurinol; Antineoplastic Agents; Child; Female; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma; Middle Aged; Polycythemia Vera; Pregnancy; Uric Acid

1979
[Use of milurit in hyperuricemia in patients with malignant hemopathies].
    Klinicheskaia meditsina, 1975, Volume: 53, Issue:3

    Topics: Adolescent; Adult; Aged; Allopurinol; Female; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Uric Acid

1975
[Serum and urine uric acid content in hemoblastoses and gout as well as its modification by allopurinol].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1971, Apr-01, Volume: 26, Issue:7

    Topics: Allopurinol; Bone Marrow Diseases; Gout; Hodgkin Disease; Humans; Leukemia; Leukemia, Myeloid; Plasmacytoma; Polycythemia Vera; Uric Acid

1971